English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 906009 Online Users : 625
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
生技與藥物研究所
徐祖安
--期刊論文
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
生技與藥物研究所
>
徐祖安
>
期刊論文
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Loading...
Siblings
會議論文/會議摘要
[
27
/39]
專利
[
0
/32]
Collection Statistics
近3年內發表的文件:8(5.56%)
含全文筆數:143(99.31%)
文件下載次數統計
下載大於0次:143(100.00%)
下載大於100次:141(98.60%)
檔案下載總次數:87248(84.49%)
最後更新時間: 2024-12-01 01:23
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
Development of a humanized antibody...
Reducing brain Abeta burden amelior...
Development of furanopyrimidine-bas...
Targeting the phosphatidylserine-im...
Synthesis and evaluation of small m...
Extracellular HSP90alpha induces My...
The beneficial effects of combining...
Acyl-coenzyme a synthetase long-cha...
Colloidal assemblies composed of po...
The effects of Abeta1-42 binding to...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 1-10 of 144. (15 Page(s) Totally)
1
2
3
4
5
6
7
8
9
10
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2024-07-04
Development of a humanized antibody targeting extracellular HSP90alpha to suppress endothelial-mesenchymal transition-enhanced tumor growth of pancreatic adenocarcinoma cells
Cells. 2024 Jul 04;13(13):Article number 1146.
2024-04
Reducing brain Abeta burden ameliorates high-fat diet-induced fatty liver disease in APP/PS1 mice
Biomedicine and Pharmacotherapy. 2024 Apr;173:Article number 116404.
2023-02-07
Development of furanopyrimidine-based orally active third-generation EGFR inhibitors for the treatment of non-small cell lung cancer
Journal of Medicinal Chemistry. 2023 Feb 7;66(4):2566-2588.
2022-10-13
Targeting the phosphatidylserine-immune checkpoint with a small-molecule maytansinoid conjugate
Journal of Medicinal Chemistry. 2022 Oct 13;65(19):12802-12824.
2022-06-21
Synthesis and evaluation of small molecule drug conjugates harnessing thioester-linked maytansinoids
Pharmaceutics. 2022 Jun 21;14(7):Article number 1316.
2022-01-18
Acyl-coenzyme a synthetase long-chain family member 4 is involved in viral replication organelle formation and facilitates virus replication via ferroptosis
mBio. 2022 Jan 18;13(1):Article number e0271721.
2022-01-11
Extracellular HSP90alpha induces MyD88-IRAK complex-associated IKKalpha/Beta−NF-KappaB/IRF3 and JAK2/TYK2−STAT-3 signaling in macrophages for tumor-promoting M2-polarization
Cells. 2022 Jan 11;11(2):Article number 229.
2022-01-05
The beneficial effects of combining anti-Abeta antibody NP106 and curcumin analog TML-6 on the treatment of Alzheimer’s disease in APP/PS1 mice
International Journal of Molecular Sciences. 2022 Jan 5;23(1):Article number 556.
2021-07-30
The effects of Abeta1-42 binding to the SARS-CoV-2 spike protein S1 subunit and angiotensin-converting enzyme 2
International Journal of Molecular Sciences. 2021 Jul 30;22(15):Article number 8226.
2021-07-16
Colloidal assemblies composed of polymeric micellar/emulsified systems integrate cancer therapy combining a tumor-associated antigen vaccine and chemotherapeutic regimens
Nanomaterials. 2021 Jul 16;11(7):Article number 1844.
Showing items 1-10 of 144. (15 Page(s) Totally)
1
2
3
4
5
6
7
8
9
10
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback